Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

about

Osteoradionecrosis of the jaw in a patient with lymphoma treated with rituximab and concomitant involved field radiation therapy

P2860

Q58131159-2682196C-18CB-4FF3-B061-F65B8A105617

P2860

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

Item

http://www.wikidata.org/entity/Q47830676

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@en

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@nl

type

Item

label

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@en

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@nl

prefLabel

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@en

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@nl

P1476

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

@en

P2093

Alberto Bosi

http://www.w3.org/2001/XMLSchema#string

Alberto Fabbri

http://www.w3.org/2001/XMLSchema#string

Benedetta Puccini

http://www.w3.org/2001/XMLSchema#string

Emanuele Cencini

http://www.w3.org/2001/XMLSchema#string

Gabriele Simontacchi

http://www.w3.org/2001/XMLSchema#string

Gemma Benelli

http://www.w3.org/2001/XMLSchema#string

Lara Mannelli

http://www.w3.org/2001/XMLSchema#string

Luigi Rigacci

http://www.w3.org/2001/XMLSchema#string

Monica Bocchia

http://www.w3.org/2001/XMLSchema#string

Sofia Kovalchuk

http://www.w3.org/2001/XMLSchema#string

P2860

Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1387909

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28994343

http://www.w3.org/2001/XMLSchema#string

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

about

P2860

P2860

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698